Jaguar Health (JAGX) Receivables - Other (2014 - 2026)
Jaguar Health (JAGX) reported Receivables - Other of $212000.0 for Q1 2026, up 27.71% year-over-year from $166000.0 in Q1 2025, and up 19.77% quarter-over-quarter from $177000.0 in Q4 2025.
Jaguar Health (JAGX) Receivables - Other (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Receivables - Other data on file, last reported at $212000.0 in Q1 2026.
- Receivables - Other for Q1 2026 came in at $212000.0, up 27.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $212000.0 (up 27.71% YoY), and the FY2025 annual result was $177000.0, up 47.5% from the prior year.
- Receivables - Other improved to $212000.0 in Q1 2026 per JAGX's latest filing, from $177000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $634000.0 in Q3 2022 and troughed at $57000.0 in Q3 2024.
- A 5-year average of $260176.5 and a median of $177000.0 in 2025 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other jumped 1433.33% in 2022, then sank 73.03% in 2023.
- A 5-year view of Receivables - Other shows it stood at $588000.0 in 2022, then plunged by 63.1% to $217000.0 in 2023, then tumbled by 44.7% to $120000.0 in 2024, then jumped by 47.5% to $177000.0 in 2025, then advanced by 19.77% to $212000.0 in 2026.
- Business Quant data shows JAGX's Receivables - Other at $212000.0 in Q1 2026, $177000.0 in Q4 2025, and $67000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 143,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Dec 31, 2023 | 217,000.00 |
| Dec 31, 2023 | 217,000.00 |